1. Home
  2. TRAW vs CMBM Comparison

TRAW vs CMBM Comparison

Compare TRAW & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRAW
  • CMBM
  • Stock Information
  • Founded
  • TRAW 1998
  • CMBM 2011
  • Country
  • TRAW United States
  • CMBM United States
  • Employees
  • TRAW N/A
  • CMBM N/A
  • Industry
  • TRAW
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • TRAW
  • CMBM Technology
  • Exchange
  • TRAW NYSE
  • CMBM Nasdaq
  • Market Cap
  • TRAW 7.8M
  • CMBM 9.6M
  • IPO Year
  • TRAW 2013
  • CMBM 2019
  • Fundamental
  • Price
  • TRAW $1.40
  • CMBM $0.40
  • Analyst Decision
  • TRAW
  • CMBM Strong Buy
  • Analyst Count
  • TRAW 0
  • CMBM 2
  • Target Price
  • TRAW N/A
  • CMBM $5.50
  • AVG Volume (30 Days)
  • TRAW 3.4M
  • CMBM 5.2M
  • Earning Date
  • TRAW 08-14-2025
  • CMBM 08-07-2025
  • Dividend Yield
  • TRAW N/A
  • CMBM N/A
  • EPS Growth
  • TRAW N/A
  • CMBM N/A
  • EPS
  • TRAW N/A
  • CMBM N/A
  • Revenue
  • TRAW $227,000.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • TRAW $3.81
  • CMBM N/A
  • Revenue Next Year
  • TRAW $30.43
  • CMBM $17.87
  • P/E Ratio
  • TRAW N/A
  • CMBM N/A
  • Revenue Growth
  • TRAW 0.44
  • CMBM N/A
  • 52 Week Low
  • TRAW $0.97
  • CMBM $0.23
  • 52 Week High
  • TRAW $19.44
  • CMBM $2.97
  • Technical
  • Relative Strength Index (RSI)
  • TRAW 42.63
  • CMBM 54.18
  • Support Level
  • TRAW $1.62
  • CMBM $0.38
  • Resistance Level
  • TRAW $1.77
  • CMBM $0.41
  • Average True Range (ATR)
  • TRAW 0.15
  • CMBM 0.04
  • MACD
  • TRAW -0.03
  • CMBM 0.01
  • Stochastic Oscillator
  • TRAW 10.34
  • CMBM 90.38

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: